- Home
- Health & Fitness
- Diseases
- Prostate Cancer Decoded (Non-Invasive Breakthrough Treatments)
Prostate Cancer Decoded (Non-Invasive Breakthrough Treatments)
List Price:
$17.95
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Robert L Bard
Format:
Paperback
Pages:
168
Publisher:
Morgan James Publishing (December 1, 2007)
Language:
English
Audience:
General/trade
ISBN-13:
9781600373466
ISBN-10:
1600373461
Weight:
17.44oz
Dimensions:
7.04" x 10.03" x 0.48"
File:
PGW-LEGATO-Metadata_Only_Publishers_Group_West_Customer_Group_Metadata_20250917130142-20250917.xml
Folder:
PGW
List Price:
$17.95
Country of Origin:
United States
Case Pack:
26
As low as:
$13.82
Publisher Identifier:
P-PER
Discount Code:
A
Pub Discount:
65
Imprint:
Morgan James Publishing
Overview
The Facts of Prostate Cancer 2/3 of men over age 50 have low grade tumors or potential cancer cells in their prostate. Only 10% will develop clinically aggressive prostate cancer. These non-invasive exams tell if a tumor is aggressive or not with an accuracy exceeding traditional biopsy results and correlate well with prognosis according to the latest international cancer conferences. The PSA test has a poor correlation with cancer detection. The digital rectal exam is more accurate in detecting high grade tumors than the PSA level. Biopsies are random, invasive and may spread tumor cells. New non-invasive treatments are guided by advanced radiologic imaging technologies. The therapeutic effect is serially studied by MRI and 3-D sonography. While generally successful, interval exams may document an unsatisfactory response, allowing ""standard"" treatments to be started, if necessary, in a timely manner.
